A NSW Government website

On

Colorectal Surgery Research

The Colorectal Department has created a foundation in evidence-based practice through their close ties to the Surgical Outcomes Research Centre (SOuRCe), established in 2002. Through this multidisciplinary collaboration within the Sydney Local Health District and the University of Sydney, the Department's research agenda addresses diverse aspects of surgical outcomes, including surgical effectiveness, patient reported outcomes and quality of life, patterns of care and evidence-based practice, health economic evaluation, assessment of patient preferences, surgical decision-making and other methodological studies.

Over many years, the Department has become one of the major research-focused units. With support from over $30 million in competitive funding (including major funding bodies such as the NHMRC, MRFF, CINSW, NIHR and others) and a multi-disciplinary approach, the Department has published in many of the top surgical and medical journals, including NATURE, BMJ, JAMA surgery, Annals of Surgery, The British Journal of Surgery, Journal of Surgical Oncology and other high impact journals. Additionally, the Department is supportive of young academic surgeons, having assisted in the supervision of PhD and MPhil and MD students. These achievements have contributed significantly to the enhancement of patient outcomes and have changed clinical practice at RPA, Australia and Internationally.

Our Research Team

Associate Professor Chris Byrne Head of Department
Professor Michael Solomon Research Lead
Associate Professor Cherry Koh Research Lead
Dr Peter Lee Colorectal Surgeon, Masters Student
Dr Nabila Ansari Colorectal Surgeon
Dr Kirk Austin Colorectal Surgeon
Dr Kheng-Seong Ng Colorectal Surgeon
Associate Professor Jonathan Hong Colorectal Surgeon
Associate Professor Daniel Steffens SOuRCe Director
Dr Sascha Karunaratne Advanced GI Surgery Program Manager
Melanie Carne Pelvic Exenteration Research Officer
Kaheesha Rai Peritoneal Malignancy Research Officer
Lylee Ye Retroperitoneal Sarcoma Research Officer
Tiffany Tsoukalas Prehabilitation Research Officer, PhD Student
Claire Jeon Prehabilitation Research Officer
Zirong Bai PhD Candidate
Dr Kilian Brown PhD Candidate
Dr Elizabeth Connolly PhD Candidate
Dr Hugh Giddings PhD Candidate
Tiffany Tsoukalas PhD Candidate
Kate Wilson PhD Candidate
Dr Assad Zahid PhD Candidate
Dr Celine Garrett Masters Student
Dr Ashley Jenkin Masters Student
Dr Charlotte Johnstone Masters Student
Dr Pratik Raichurkar Masters Student
Dr Philip Yang Masters Student
Dr Hang Yue Siu Masters Student
Dr Jacob Waller Masters Student

Selected Grants

Amount awarded Grant and project details
$4,995,331 Medical Research Future Fund (MRFF), 2024-2029
Virtual Multimodal Hub for Patients Undergoing Major Gastrointestinal Cancer Surgery – PRIORITY-CONNECT 2 Randomised Type I Hybrid Effectiveness-Implementation Trial
Investigator: Steffens D (CIA).
$120,000 The University of Sydney, 2024-2027
PRIORITY-CONNECT SMS - Enhancing upper gastrointestinal cancer surgery recovery with AI-driven avatar-based video multidisciplinary intervention.
Investigators: Beckenkamp P, Sandroussi C, Boscolo A, Solomon M, Hush J,  Steffens D.
$998,608 MRFF - 2021 Rare Cancers, Rare Diseases and Unmet Need, 2021-ongoing
INTER-EWING-1 International clinical research program to improve outcomes in newly diagnosed Ewing Sarcoma patients Trial 1.
Investigators: McCowage G, Desai J, Phillips M, Ryan J, Hong A, Lewin J, Kirby M, Brennan B, Strong R, Stalley P.
$901,695 MRFF - 2020 Rare Cancers, Rare Diseases and Unmet Need, 2020-ongoing
A randomized phase III study of neoadjuvant chemotherapy followed by surgery versus surgery alone for patients with High Risk RetroPeritoneal Sarcoma (STRASS 2).
Investigators: Gyorki D, Grimison P, Hofman  M, Blinman P, Barbour A, Gronchi A, Snow H.
$1,119,877 NHMRC, 2020-2024
PRIORITY TRIAL - Preoperative exercise for patients undergoing major abdominal cancer surgery: A Multicentre Randomised Controlled Trial. 
Investigators: Young J, Solomon MJ, Riedel B, Steffens D, Morton R, Denehy L, Heriot A, Koh C, Li Q, Bauman A. 

Our Publications

2024

Brown KGM, Ng KS, Solomon MJ, Chapuis PH, Koh CE, Ahmadi N, Austin KKS. Complete mesocolic excision for colon cancer: current status and controversies. ANZ J Surg. 2024 Mar;94(3):309-319. doi: 10.1111/ans.18741. Epub 2023 Oct 18.
Austin KKS, Brown KGM, Solomon MJ. En bloc lateral pelvic compartment excision during pelvic exenteration: video vignette. Br J Surg. 2024 Jan 3;111(1):znad407. doi: 10.1093/bjs/znad407.
Kanakaratne S, Hong J, Solomon MJ, Young CJ. Ileal pouch-anal anastomosis provides good functional and quality of life outcomes following proctocolectomy: A 33-year single centre experience. ANZ J Surg. 2024 Mar;94(3):404-411. doi: 10.1111/ans.18827. Epub 2023 Dec 17.
Brown KGM, Pisaniello J, Ng KS, Solomon MJ, Sutton PA, Hatcher S, Steffens D. Variation in outcome measurement and reporting in studies of pelvic exenteration for locally advanced and recurrent rectal cancer: a systematic review. Colorectal Dis. 2024 Feb;26(2):272-280. doi: 10.1111/codi.16844. Epub 2023 Dec 22.
Brown KGM, Solomon MJ. Topical haemostatic agents in surgery. Br J Surg. 2024 Jan 3;111(1):znad361. doi: 10.1093/bjs/znad361.
Steffens D, Blake J, Solomon MJ, Lee P, Austin KKS, Byrne CM, Karunaratne S, Koh CE. Trajectories of Quality of Life After Pelvic Exenteration: A Latent Class Growth Analysis. Dis Colon Rectum. 2024 Apr 1;67(4):531-540. doi: 10.1097/DCR.0000000000003080. Epub 2023 Dec 29.
Brown KGM, Solomon MJ, Sutton PA, Shin JS, Steffens D. The definition of clear resection margins in locally recurrent rectal cancer-time for consensus. Br J Surg. 2024 Jan 3;111(1):znad450. doi: 10.1093/bjs/znad450.
Hirst N, McBride K, Steffens D. Psychological Interventions in Prehabilitation Randomized Controlled Trials for Patients Undergoing Cancer Surgery: Sufficient or Suboptimal? Ann Surg Oncol. 2024 Apr;31(4):2183-2186. doi: 10.1245/s10434-023-14853-x. Epub 2024 Jan 20.
Brown KG, Ansari N, Solomon MJ. Contemporary management of advanced colorectal cancer: the Australian experience. Med J Aust. 2024 Mar 18;220(5):222-224. doi: 10.5694/mja2.52218. Epub 2024 Jan 28. Erratum in: Med J Aust. 2024 May 6;220(8):406. doi: 10.5694/mja2.52275.
Jiang W, Brown KGM, Koh C, Karunaratne S, Solomon M, Beckenkamp PR, Cole R, Steffens D. Outcome Heterogeneity in Prehabilitation Trials-Are We Comparing Apples and Oranges? J Surg Res. 2024 Apr;296:366-375. doi: 10.1016/j.jss.2023.12.042. Epub 2024 Feb 2.
PelvEx Collaborative. Beating the empty pelvis syndrome: the PelvEx Collaborative core outcome set study protocol. BMJ Open. 2024 Feb 5;14(2):e076538. doi: 10.1136/bmjopen-2023-076538.
Siu A, Steffens D, Ansari N, Karunaratne S, Solanki H, Ahmadi N, Solomon M, Moran B, Koh C. Evaluating geographical disparities on clinical outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Tech Coloproctol. 2024 Feb 20;28(1):35. doi: 10.1007/s10151-024-02911-9.
van Kessel CS, Palma CA, Solomon MJ, Leslie S, Jeffery N, Lee PJ, Austin KKS. Comparison of urological outcomes and quality of life after pelvic exenteration: partial vs radical cystectomy. BJU Int. 2024 Apr;133 Suppl 4:53-63. doi: 10.1111/bju.16299. Epub 2024 Feb 20. 
Ebrahimi N, Brown KGM, Ng KS, Solomon MJ, Lee PJ. Impact of Intraoperative Decision-Making on Pathological Margin Status in Patients Undergoing Pelvic Exenteration for Locally Recurrent Rectal Cancer. Dis Colon Rectum. 2024 Aug 1;67(8):1024-1029. doi: 10.1097/DCR.0000000000003131. Epub 2024 Feb 21.
Waller JH, van Kessel CS, Solomon MJ, Lee PJ, Austin KKS, Steffens D. Outcomes Following Pelvic Exenteration for Locally Recurrent Rectal Cancer With and Without En Bloc Sacrectomy. Dis Colon Rectum. 2024 Jun 1;67(6):796-804. doi: 10.1097/DCR.0000000000003154. Epub 2024 Feb 23.
Steffens D, Ansari N, Koh C, Ahmadi N, Solomon MJ, Hogan S, Karunaratne S, Anderson T, Harvey K, McBride K, Moran B. Complexity of surgery and treatment burden in patients with peritoneal malignancy is not determined by addition of hyperthermic intraperitoneal chemotherapy. ANZ J Surg. 2024 Apr;94(4):628-633. doi: 10.1111/ans.18933. Epub 2024 Mar 7.
PelvEx Collaborative. The empty pelvis syndrome: a core data set from the PelvEx collaborative. Br J Surg. 2024 Mar 2;111(3):znae042. doi: 10.1093/bjs/znae042. Erratum in: Br J Surg. 2024 Mar 2;111(3):znae095. doi: 10.1093/bjs/znae095.
Garrett C, Steffens D, Solomon M, Koh C. Surgical and survival outcomes of early-onset colorectal cancer patients: a single-centre descriptive Australian study. ANZ J Surg. 2024 Sep;94(9):1584-1589. doi: 10.1111/ans.18938. Epub 2024 Mar 12.
Giddings HL, Ng KS, Solomon MJ, Steffens D, Van Buskirk J, Young J. High but decreasing rates of reconstruction after total proctocolectomy for ulcerative colitis, and evidence of a direct volume outcome relationship. ANZ J Surg. 2024 Sep;94(9):1598-1609. doi: 10.1111/ans.18986. Epub 2024 Mar 25.
Steffens D, Solomon M, Dubowitz J, Martis W, Ismail H, Koh C, Riedel B. Augmented prehabilitation - is there a role for glucocorticoids and/or anabolic steroids to improve surgical outcomes? ANZ J Surg. 2024 Jun;94(6):989-992. doi: 10.1111/ans.18989. Epub 2024 Mar 25.
PelvEx Collaborative. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer. Colorectal Dis. 2024 May;26(5):926-931. doi: 10.1111/codi.16948. Epub 2024 Apr 2.
Bai Z, Solomon M, Shahab R, Koh C, Steffens D. The good, the bad, and the frail - the role of prehabilitation in frail patients undergoing cancer surgery. ANZ J Surg. 2024 Jun;94(6):993-995. doi: 10.1111/ans.19027. Epub 2024 May 8.
Giddings HL, Yang PF, Steffens D, Solomon MJ, Ng KS. Influence of hospital-level and surgeon factors on the outcomes after ileo-anal pouch surgery for inflammatory bowel disease: systematic review. Br J Surg. 2024 May 3;111(5):znae088. doi: 10.1093/bjs/znae088.
Garrett C, Koh CE, Solomon MJ, Steffens D. The health-related quality of life of early-onset colorectal cancer patients: an Australian cross-sectional study. Colorectal Dis. 2024 Jun;26(6):1166-1174. doi: 10.1111/codi.16998. Epub 2024 May 14.
Ephraums J, Brown KGM, Solomon MJ, Austin KKS, Lee PJ, Leslie S, Byrne C. Pelvic exenteration for locally advanced and recurrent prostate cancer. Eur J Surg Oncol. 2024 Jul;50(7):108384. doi: 10.1016/j.ejso.2024.108384. Epub 2024 May 7.
Garrett C, Steffens D, Ackland S, Solomon M, Koh C. Risk factors, histopathological landscape, biomarkers, treatment patterns and survival of early-onset colorectal cancer: A narrative review. Asia Pac J Clin Oncol. 2024 Aug;20(4):444-449. doi: 10.1111/ajco.14081. Epub 2024 May 22.
Hush JM, Steffens D, Solomon MJ. A patient-designed integrative oncology intervention for stage IV locally recurrent rectal cancer: A case report. Explore (NY). 2024 Sep-Oct;20(5):103004. doi: 10.1016/j.explore.2024.05.002. Epub 2024 May 21.
Lee PJ, Kim TJ, Ye L, Wu YS, Steffens D, Karunaratne S, Brown W, Karim R, Grimison P, Hong AM. SPARC - A multi-disciplinary team program for retroperitoneal sarcoma: the Royal Prince Alfred Hospital and Chris O'Brien Lifehouse Collaboration. ANZ J Surg. 2024 Jul-Aug;94(7-8):1333-1340. doi: 10.1111/ans.19102. Epub 2024 May 24.
Vu J, Koh C, Solomon M, Brown K, Karunaratne S, Cole R, Smith P, Raichurkar P, Denehy L, Riedel B; Prehabilitation Expert Collaborative; Steffens D. Patients' and carers' views on research priorities in prehabilitation for cancer surgery. Support Care Cancer. 2024 May 24;32(6):378. doi: 10.1007/s00520-024-08585-1.
Steffens D, Nott F, Koh C, Jiang W, Hirst N, Cole R, Karunaratne S, West MA, Jack S, Solomon MJ. Effectiveness of Prehabilitation Modalities on Postoperative Outcomes Following Colorectal Cancer Surgery: A Systematic Review of Randomised Controlled Trials. Ann Surg Oncol. 2024 Nov;31(12):7822-7849. doi: 10.1245/s10434-024-15593-2. Epub 2024 Jun 24.
Giddings HL, Ng KS, Solomon MJ, Steffens D, Van Buskirk J, Young J. Unexpected variation in outcomes following total (procto)colectomies for ulcerative colitis in New South Wales, Australia: a population-based 19-year linked-data study. Colorectal Dis. 2024 Aug;26(8):1584-1596. doi: 10.1111/codi.17074. Epub 2024 Jun 27.
Steffens D, Solomon MJ, Jack S, West MA. ASO Author Reflections: Improving Postoperative Outcomes in Colorectal Cancer Surgery: Where are We with Prehabilitation? Ann Surg Oncol. 2024 Oct;31(10):6474-6475. doi: 10.1245/s10434-024-15835-3. Epub 2024 Jul 11.
Vu JK, Koh CE. Prehabilitation for Colorectal Cancer Surgery. Dis Colon Rectum. 2024 Oct 1;67(10):1239-1242. doi: 10.1097/DCR.0000000000003456. Epub 2024 Jul 17.
Brown KGM, Solomon MJ. Understanding Quality of Life After Pelvic Exenteration for Patients with Rectal Cancer. Ann Surg Oncol. 2024 Nov;31(12):7668-7670. doi: 10.1245/s10434-024-16031-z. Epub 2024 Aug 13.
Makker PGS, Koh CE, Solomon M, El-Hayek J, Kim B, Steffens D. The influence of postoperative morbidity on long-term quality of life outcomes following pelvic exenteration. Eur J Surg Oncol. 2024 Nov;50(11):108640. doi: 10.1016/j.ejso.2024.108640. Epub 2024 Aug 24.
Risbey CWG, Brown KGM, Solomon M, McBride K, Steffens D. Cost Analysis of Pelvic Exenteration Surgery for Advanced Pelvic Malignancy. Ann Surg Oncol. 2024 Dec;31(13):9079-9087. doi: 10.1245/s10434-024-16227-3. Epub 2024 Sep 16.
Siu A, Steffens D, Ansari N, Karunaratne S, Solanki H, Ahmadi N, Solomon M, Koh C. Evaluating patient experience and healthcare utilisation in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Aust Health Rev. 2024 Oct;49:AH24192. doi: 10.1071/AH24192.
Steffens D, Koh C, Hirst N, Cole R, Solomon MJ, Nguyen-Lal L, Thanigasalam R, Leslie S, Ahmadi N. Prehabilitation in patients undergoing bladder cancer surgery - A systematic review and meta-analysis. Can J Urol. 2024 Oct;31(5):12004-12012.
Alnakli AAA, Mohamedali A, Heng B, Chan C, Shin JS, Solomon M, Chapuis P, Guillemin GJ, Baker MS, Ahn SB. Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative management. BJC Rep. 2024 Feb 13;2(1):13. doi: 10.1038/s44276-024-00043-z.
Brown KGM, Morkaya J, Solomon MJ, Ng KS, White K, Sutton P, Winter DC; EvigSurg Collaborative Group; Steffens D. Priority outcomes of pelvic exenteration for rectal cancer: a patient, carer, and clinician consensus. Br J Surg. 2024 Nov 27;111(12):znae298. doi: 10.1093/bjs/znae298.
Mohamedali A, Heng B, Amirkhani A, Krishnamurthy S, Cantor D, Lee PJM, Shin JS, Solomon M, Guillemin GJ, Baker MS, Ahn SB. A Proteomic Examination of Plasma Extracellular Vesicles Across Colorectal Cancer Stages Uncovers Biological Insights That Potentially Improve Prognosis. Cancers (Basel). 2024 Dec 21;16(24):4259. doi: 10.3390/cancers16244259.
Bartyn J, Morkaya J, Karunaratne S, Chen TY, Solomon M, Koh C, Sandroussi C, Steffens D. Factors Associated with Days Alive and at Home within 30 Days (DAH30) Scores Following Surgery: A Systematic Review. Gastrointestinal Disorders. 2024 Dec 1;6(4). doi: 10.3390/gidisord6040057.
Makker P, Pillinger N, Ansari N, Koh C, Solomon M, Steffens D. Correlation between preoperative cardiopulmonary exercise testing and six-minute walk test, five-times sit to stand test and Short Form-36 physical component score in patients undergoing cytoreductive surgery. Surg Onc Ins. 2024 Jun;1(2):100052. doi: 10.1016/j.soi.2024.100052.
Raichurkar P, Brown K, Ansari N, Koh C, Ahmadi N, Solomon M, Moran B, Steffens D. Developing a core outcome set for cytoreductive surgery for colorectal cancer with peritoneal metastases: A mixed-method study protocol. Gastrointest Disord. 2024 Jan; 6(1):143-151. doi: 10.3390/gidisord6010010.
Steffens D, Koh C, Smith A, Mohan H, Carey S, Smith S, Poulton T, Patton V, White K, Laranjo L, Dieng M, Liu X, Denehy L, Wilson K, Allman-Farinelli M, Butow P, Riedel B, Morton RL, Hassett L, Li Q, Delbaere K, Hutchings O, Martin O, Dhillon H, Shailer B, Beardsworth G, Salter M, Cherry K, Rubie F, Reece L, Chan A, Shabab R, Dwyer O, Pring K, Cunningham D, Sheehan K, Iori G, Johnander R, Cole R, Hirst N, Solomon M. Virtual multimodal hub for patients undergoing major gastrointestinal cancer surgery (PRIORITY-CONNECT 2) - A pilot randomised type I hybrid effectiveness-implementation trial. Surgical Oncology Insight 2024; 1(3):Sept:100082. doi: 10.1016/j.soi.2024.100082.
Steffens D, Makker PGS, Ansari N, Solomon MJ, Solanki H, Moran B, Koh C.   The influence of postoperative morbidity on medium to long-term quality of life trajectories following cytoreductive surgery for peritoneal malignancy: A prospective cohort study. Surg Onc Ins. 2024 Mar; 1(1):100004. doi: /10.1016/j.soi.2023.100004.
Steffens D, Nott F, Koh C, Jiang W, Hirst N, Cole R, Karunaratne S, West MA, Jack S, Solomon MJ. ASO Visual Abstract: Effectiveness of Prehabilitation Modalities on Postoperative Outcomes Following Colorectal Cancer Surgery: A Systematic Review of Randomised Controlled Trials. Annals of Surgical Oncology 2024. doi: 10.1245/s10434-024-15978-3.